Central Venous Pressure Guided Hydration Prevention for Contrast-Induced Nephropathy
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 264 participants.
Also called NCT02405377
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 264 participants
- Sponsor
- Registry
-
NCT02405377
-
- Other papers using this trial's data
- Prevention of Contrast-Induced Nephropathy by Central Venous Pressure-Guided Fluid Administration in Chronic Kidney Disease and Congestive Heart Failure Patients
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT02405377. Randomized; triple masking; primary purpose prevention. Start 2014-02 (registry gives no type); primary completion 2015-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Central Venous Pressure Guided Hydration Prevention for Contrast-Induced Nephropathy
- Condition
- Cardio-Renal Syndrome
- Intervention (Procedure)
- hydration
- Intervention (Drug)
- Visipaque
- Intervention (Drug)
- 0.9% sodium chloride fluid administration
- Intervention (Device)
- 5-French catheter
- Lead sponsor
- Chinese PLA General Hospital
Record details
- Record id
cardio:ct-nct02405377- Content hash
16ae1a2389850fb9cd48fd79a56cdc7931adf1b78f40d0d24a0004a070b3e08d